Description: The CIA, CAS Institute (iCAS) and the Society of Actuaries (SOA) are joining forces once again to launch the Predictive Analytics Hack-A-Thon!

Description: Predictive analytics projects in the life insurance industry are oftentimes set up as research ideas leading to intangible or unusable results for the practicing actuary. What if you could change that? What if the research turned into development and practical use through leveraging valuable resources properly? Learn how to structure predictive analytics projects, and about the project team, so there will be actionable takeaways for the business unit. Specific areas of value for you include underwriting, experience studies, assumption-setting, and product development. Watch as presenters talk through real case studies on turning a predictive analytics project into workable solutions rather than a resource drain, an unclear goal, or a misunderstood business need, which are some of the pitfalls of a poorly planned project.

Description: Explore wellness programs and their effectiveness within the LTC industry by attending the Considerations for LTC Wellness Programs webcast. You will experience discussions about design tactics and evaluation processes for programs, as well as discovering ways to assist policyholders achieve a sustainable and equitable life. There will also be a conversation about the current regulatory environment as it relates to LTC wellness programs. This webinar will focus on subsets of insured populations that are high risk of claim in order to properly manage care decisions and ensure unfair bias is avoided. Learn how to test for unfair bias and determine best possibilities on how to guard against this when testing is unavailable.

Description: Discover the key components of value-based care (VBC) contracts and their impact on provider credibility. Learn about benchmarks, measurement period results, and the unique challenges providers face in managing insurance risk. Gain insights into reducing costs and aligning financial incentives in the US healthcare market.

Description: Term products exhibit a wide range of behavior as policyholders can elect different term periods and conversion options. While term products have been around for decades, it's only recently that longer level term products are reaching the end of the level term period. Term conversions have historically been an afterthought and are rarely modeled. Discuss the use of predictive modeling techniques such as LASSO regression and cross-validation to build models for level term lapses and post-level term shock lapses, as well as the extrapolation of experience for shorter term products to longer term products (e.g., extrapolating 20-year term experience and applying to 30-year term). Explore the use of traditional techniques to develop term conversion rates and a framework for modeling the assumption. Challenges and limitations of setting lapse and conversion rates will be discussed. By attending the session, you will: - Understand the complexities of term policyholder behavior. - Understand the challenges in developing and implementing assumptions for lapses and conversions. - Understand the application of traditional and predictive modeling techniques for term policyholder behavior.

Description: Insurance carriers today must balance a multitude of factors to remain relevant and innovate- -process improvements and efficiency (automated or traditional); -customer experience (less intrusive, more data); -distribution (aging traditional, product focus, emerging opportunities); and -mortality. While these factors are not new, true innovation in these areas require a convergence of engagement among actuaries, underwriters and data scientists to determine the specific pain points and appreciate both the benefits and consequences of various paths. Explore examples of how best to approach these topics, engage different disciplines, avoid pitfalls and ensure a holistic view. Real life examples and lessons learned will be shared during this session.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: Hop into a panel discussion between InsurTech Advisory Council and a startup, followed by a demo of life event prediction and analyses with multiple applications across financial services. You will also learn about: the SOA office hours program and member participation, the startup ecosystem filled with incubators, company contests, opportunities and outcomes, how to build a data set providing additional insights for customization and enhanced user experience, and - actuaries' engagement with startup strategic advisory boards.

Description: An introductory article describing how Bayesian statistics has evolved over the past 20 years and why it offers the actuarial discipline powerful tools to better understand and manage risk. Compared with traditional (frequentist) and black-box (machine learning) approaches, Bayesian analysis provides explainable models focused on distributions of estimates instad of simply point estimates.